ストックスクリーナーアプリを入手
2.105
4.32%
-0.095
前日終値:
$2.20
開ける：
$2.16
24時間の取引高:
14,124
Relative Volume:
0.20
時価総額：
$25.81M
収益：
-
当期純損益:
$-3.15M
株価収益率:
-6.8971
EPS:
-0.3052
ネットキャッシュフロー:
$-2.23M
1週間 パフォーマンス:
-13.02%
1か月 パフォーマンス:
+4.73%
6か月 パフォーマンス:
-9.27%
1年 パフォーマンス:
-8.68%
1日の値動き範囲:
$2.09
$2.17
1週間の範囲:
$2.09
$2.45
52週間の値動き範囲:
$1.65
$4.0499
Cytomed Therapeutics Ltd Stock (GDTC) Company Profile
GDTC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GDTC
Cytomed Therapeutics Ltd
|
2.115 | 25.81M | 0 | -3.15M | -2.23M | -0.3052 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.74 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.36 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.06 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
825.25 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.22 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Cytomed Therapeutics Ltd (GDTC) 最新ニュース
Can CytoMed Therapeutics Limited stock deliver surprise earnings beatJuly 2025 Final Week & Verified Momentum Stock Watchlist - newser.com
CytoMed Therapeutics Limited stock trend outlook and recovery path2025 Breakouts & Breakdowns & Free Reliable Trade Execution Plans - newser.com
CytoMed Therapeutics Limited recovery potential after sell offGap Up & Weekly Return Optimization Plans - newser.com
Is a relief rally coming for CytoMed Therapeutics Limited holdersTrade Risk Summary & Free Growth Oriented Trading Recommendations - newser.com
Will CytoMed Therapeutics Limited stock split attract more investorsMarket Sentiment Report & Growth Focused Stock Reports - newser.com
What earnings revisions data tells us about CytoMed Therapeutics Limited2025 Volume Leaders & Intraday High Probability Setup Alerts - newser.com
Chart based analysis of CytoMed Therapeutics Limited trendsDividend Hike & Long-Term Growth Plans - newser.com
Can CytoMed Therapeutics Limited (F98) stock sustain double digit ROEJuly 2025 Volume & Daily Entry Point Alerts - newser.com
Using fundamentals and technicals on CytoMed Therapeutics LimitedSell Signal & Technical Pattern Recognition Alerts - newser.com
What MACD and RSI say about CytoMed Therapeutics Limited2025 Geopolitical Influence & Growth Focused Entry Reports - newser.com
CytoMed Therapeutics Limited stock outlook for YEARWeekly Investment Report & Community Trade Idea Sharing - newser.com
Will CytoMed Therapeutics Limited (F98) stock keep high P E multiplesJuly 2025 Reactions & Free Safe Capital Growth Stock Tips - newser.com
How CytoMed Therapeutics Limited (F98) stock responds to bond marketCEO Change & Long-Term Safe Investment Plans - newser.com
Should you wait for a breakout in CytoMed Therapeutics Limited2025 Risk Factors & Expert Approved Momentum Ideas - newser.com
Why CytoMed Therapeutics Limited stock appeals to dividend seekersJuly 2025 Spike Watch & Real-Time Chart Breakout Alerts - newser.com
Long term hold vs stop loss in CytoMed Therapeutics Limited2025 Price Targets & High Accuracy Trade Alerts - newser.com
Why CytoMed Therapeutics Limited stock could benefit from AI revolutionNew Guidance & Reliable Price Breakout Alerts - newser.com
Published on: 2025-10-25 16:06:34 - newser.com
What does recent volatility data suggest for CytoMed Therapeutics Limited2025 Volume Leaders & Fast Entry Momentum Alerts - newser.com
What recovery options are there for CytoMed Therapeutics LimitedEarnings Summary Report & Free Real-Time Market Sentiment Alerts - newser.com
What insider purchases suggest about CytoMed Therapeutics Limited (F98) stockJuly 2025 Momentum & Weekly Market Pulse Alerts - newser.com
Can you recover from losses in CytoMed Therapeutics Limited2025 Technical Patterns & Consistent Profit Trade Alerts - newser.com
Heatmap analysis for CytoMed Therapeutics Limited and competitorsPortfolio Update Report & Precise Buy Zone Identification - newser.com
Can CytoMed Therapeutics Limited recover in the next quarter2025 Big Picture & Scalable Portfolio Growth Ideas - newser.com
Cytomed Therapeutics Ltd (GDTC) 財務データ
収益
当期純利益
現金流量
EPS
0.29%
0.16%
大文字化:
|
ボリューム (24 時間):